Nitric Oxide in Myogenesis and Therapeutic Muscle Repair

被引:0
作者
Clara De Palma
Emilio Clementi
机构
[1] Università di Milano,Unit of Clinical Pharmacology, Consiglio Nazionale delle Ricerche Institute of Neuroscience, Department of Biomedical and Clinical Sciences L. Sacco, University Hospital “Luigi Sacco”
[2] E. Medea Scientific Institute,undefined
来源
Molecular Neurobiology | 2012年 / 46卷
关键词
Nitric oxide; Duchenne muscular dystrophy; Myogenesis; Muscle repair; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Nitric oxide is a short-lived intracellular and intercellular messenger. The first realisation that nitric oxide is important in physiology occurred in 1987 when its identity with the endothelium-derived relaxing factor was discovered. Subsequent studies have shown that nitric oxide possesses a number of physiological functions that are essential not only to vascular homeostasis but also to neurotransmission, such as in the processes of learning and memory and endocrine gland regulation, as well as inflammation and immune responses. The discovery in 1995 that a splice variant of the neuronal nitric oxide synthase is localised at the sarcolemma via the dystrophin–glycoprotein complex and of its displacement in Duchenne muscular dystrophy has stimulated a host of studies exploring the role of nitric oxide in skeletal muscle physiology. Recently, nitric oxide has emerged as a relevant messenger also of myogenesis that it regulates at several key steps, especially when the process is stimulated for muscle repair following acute and chronic muscle injuries. Here, we will review briefly the mechanisms and functions of nitric oxide in skeletal muscle and discuss its role in myogenesis, with specific attention to the promising nitric oxide-based approaches now being explored at the pre-clinical and clinical level for the therapy of muscular dystrophy.
引用
收藏
页码:682 / 692
页数:10
相关论文
共 773 条
  • [1] Palmer RM(1987)Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 524-526
  • [2] Ferrige AG(1980)The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 373-376
  • [3] Moncada S(2001)Nitric oxide synthases: structure, function and inhibition Biochem J 357 593-615
  • [4] Furchgott RF(1991)Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 109-142
  • [5] Zawadzki JV(1997)Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action Diabetes 46 1691-1700
  • [6] Alderton WK(1998)Involvement of nitric oxide system in experimental muscle crush injury J Clin Invest 101 1325-1333
  • [7] Cooper CE(1997)Evidence that nitric oxide increases glucose transport in skeletal muscle J Appl Physiol 82 359-363
  • [8] Knowles RG(1998)Cell death and oxidative damage in inflammatory myopathies Clin Immunol Immunopathol 87 240-247
  • [9] Moncada S(2003)Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide Am J Physiol 285 F178-F190
  • [10] Palmer RM(1997)Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain J Biol Chem 272 28187-28190